Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Poulter

Showing results (41-50 of 179) with videos related to

Pageof 18
Sort By:
BMJ (Clinical Research Ed.)|June 10, 2010
Community based lifestyle intervention for blood pressure reduction in children and young adults in developing country: cluster randomised controlled trialTazeen H Jafar, Muhammad Islam, Juanita Hatcher, et al.
Diabetes, Obesity & Metabolism|June 2, 2020
Sex-specific associations between cardiovascular risk factors and myocardial infarction in patients with type 2 diabetes: The ADVANCE-ON studyToshiaki Ohkuma, Sanne A E Peters, Min Jun, et al.
European Heart Journal|April 20, 2020
Chronotherapy in hypertension: the devil is in the detailsGreg Guthrie, Neil Poulter, Thomas Macdonald, et al.
Diabetes Care|December 11, 2024
Intensive Glucose Lowering and Its Effects on Vascular Events and Death According to Age at Diagnosis and Duration of Diabetes: The ADVANCE TrialToshiaki Ohkuma, Katie Harris, Mark Woodward, et al.
Hypertension (Dallas, Tex. : 1979)|December 11, 2013
Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trialJohn Chalmers, Hisatomi Arima, Mark Woodward, et al.
Diabetes, Obesity & Metabolism|February 21, 2019
Fixed-ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulinTina Vilsbøll, Thomas C Blevins, Esteban Jodar, et al.
BMJ Open|September 3, 2013
Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional studyMichel Joffres, Emanuela Falaschetti, Cathleen Gillespie, et al.
Journal of Hypertension|September 9, 2024
Combination blood pressure lowering therapy in patients with type 2 diabetes: messages from the ADVANCE trialNelson Wang, John Chalmers, Katie Harris, et al.
Diabetes Care|March 21, 2020
Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A<sub>1c</sub> in the ADVANCE TrialJingyan Tian, Toshiaki Ohkuma, Mark Cooper, et al.
Diabetes, Obesity & Metabolism|September 11, 2024
Lipids and apolipoproteins and the risk of vascular disease and mortality outcomes in women and men with type 2 diabetes in the ADVANCE studyMiriam Pikkemaat, Mark Woodward, Peder Af Geijerstam, et al.
Pageof 18

Showing results (41-50 of 179) with videos related to

Sort By:
Pageof 18
BMJ (Clinical Research Ed.)|June 10, 2010
Community based lifestyle intervention for blood pressure reduction in children and young adults in developing country: cluster randomised controlled trialTazeen H Jafar, Muhammad Islam, Juanita Hatcher, et al.
Diabetes, Obesity & Metabolism|June 2, 2020
Sex-specific associations between cardiovascular risk factors and myocardial infarction in patients with type 2 diabetes: The ADVANCE-ON studyToshiaki Ohkuma, Sanne A E Peters, Min Jun, et al.
European Heart Journal|April 20, 2020
Chronotherapy in hypertension: the devil is in the detailsGreg Guthrie, Neil Poulter, Thomas Macdonald, et al.
Diabetes Care|December 11, 2024
Intensive Glucose Lowering and Its Effects on Vascular Events and Death According to Age at Diagnosis and Duration of Diabetes: The ADVANCE TrialToshiaki Ohkuma, Katie Harris, Mark Woodward, et al.
Hypertension (Dallas, Tex. : 1979)|December 11, 2013
Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trialJohn Chalmers, Hisatomi Arima, Mark Woodward, et al.
Diabetes, Obesity & Metabolism|February 21, 2019
Fixed-ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulinTina Vilsbøll, Thomas C Blevins, Esteban Jodar, et al.
BMJ Open|September 3, 2013
Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional studyMichel Joffres, Emanuela Falaschetti, Cathleen Gillespie, et al.
Journal of Hypertension|September 9, 2024
Combination blood pressure lowering therapy in patients with type 2 diabetes: messages from the ADVANCE trialNelson Wang, John Chalmers, Katie Harris, et al.
Diabetes Care|March 21, 2020
Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A<sub>1c</sub> in the ADVANCE TrialJingyan Tian, Toshiaki Ohkuma, Mark Cooper, et al.
Diabetes, Obesity & Metabolism|September 11, 2024
Lipids and apolipoproteins and the risk of vascular disease and mortality outcomes in women and men with type 2 diabetes in the ADVANCE studyMiriam Pikkemaat, Mark Woodward, Peder Af Geijerstam, et al.
Pageof 18